Abstract:There have been many literatures reporting the binding performance of transition metal complexes towards DNA, aiming at anti-cancer and anti-tumor drugs. However, most of these references focused on divalent transition metal cations, such as Co(II), Ni(II), Cu(II) and Zn(II). Only a few efforts have been devoted to high-valent transition metal cations. In this paper, we synthesized two Co(II) and Co(III) complexes, tris{2-(pyridin-2-yl)benzo[d]imidazole-1-ide}-cobalt(III) [denoted as Co(L)3] and bis{2-(pyridin-2-yl)benzo[d]imidazole-1-ide}-{2-(pyridin-2-yl)-1H-benzo[d]imidazole}-cobalt(II) [denoted as Co(HL)(L)2], using a diamine ligand 2-(pyridin-2-yl)-1H-benzo[d]imidazole (denoted as HL). Their molecular structure was identified with their single crystals, MS and NMR spectra. Co(L)3 and Co(HL)(L)2 share the same crystal system (monoclinic) and space group (P21/c). Their crystal cell parameters were found rather similar to each other owing to their rather similar ligands, showing a slightly distorted octahedron coordination geometry. No intramolecular interaction, superamolecular interactions and π-π staking between neighboring Co(L)3 molecules or neighboring Co(HL)(L)2 molecules were found, forming a clean coordination environment. Density functional theory calculation on their single crystals suggested that they had similar onset electronic transitions. Their thermal stability, absorption and emission were compared. Owing to their rather similar molecular structures, most of their features were similar. Their binding performance for calf thymus DNA (CT-DNA) was then analyzed and compared. The binding mode between two Co complexes and CT-DNA was analyzed and confirmed by means of viscosity monitoring, circular dichroism analysis, SEM and XRD comparison. Their binding constants were determined as 974.89 M-1 for Co(L)3 and 829.25 M-1 for Co(HL)(L)2, respectively. We found a hydrogen bond between Co(L)3 and CH3OH. No hydrogen bonds were found in Co(HL)(L)2. This result suggested that the Co(L)3 interact with Ct-DNA via the combination of hydrogen bond and weak intermolecular interaction with DNA, while Co(HL)(L)2 interacts with Ct-DNA via only weak intermolecular interaction with DNA. These values were two fold higher than those of literature values (<450 M−1), indicating their potential for DNA treatment.

Synthesis and crystal structure determination of cobalt(II) mixed-ligand complex containing 1,10-phenanthroline and 5-(2-carboxybenzyloxy)isophthalic acid: Their biological evaluation viz. DNA/protein binding profile, pBR322 DNA cleavage activity

Synthesis, physicochemical, quantitative analysis and crystal structures of two mononuclear diperchlorate cobalt(II) complexes of 1,10-phenanthroline: antimicrobial, cytotoxicity and DNA/BSA interaction studies

Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

Crystal structure, DNA interaction, and antiproliferative activity of the cobalt(II) complex of demethylcantharate and imidazole

Synthesis, spectral characterization, protein binding and cytotoxic evaluation of new cobalt(II) and cobalt(III) complexes containing benzimidazolylterpyridine as ligand

An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects

Bio-relevant Cobalt(ii) Complexes with Compartmental Polyquinoline Ligand: Synthesis, Crystal Structures and Biological Activities.

Crystal Structures, Dna Interaction and Growth Inhibitory Activities of the Cobalt(Ii) and Nickel(Ii) Complexes of 2-Aminothiazole with Demethylcantharate

Crystal structure, Hirshfeld surface analysis, molecular modeling, electrochemical properties, and of a novel binuclear Co(II) complex

Cobalt (II) complex with novel unsymmetrical tetradentate Schiff base (ON) ligand: in vitro cytotoxicity studies of complex, interaction with DNA/protein, molecular docking studies, and antibacterial activity

A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.

Experimental and molecular modelling demonstration of effective DNA and protein binding as well as anticancer potential of two mononuclear Cu(II) and Co(II) complexes with isothiocyanate and azide as anionic residues

Synthesis, characterization, and cancer cell-selective cytotoxicity of mixed-ligand cobalt(III) complexes of 8-hydroxyquinolines and phenanthroline bases

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Supramolecular Co (II) Complex Fabricated From Adenine Derivative: Synthesis, Crystal Structure, Hirshfeld Surface, DFT Optimization, Anticancer, and Molecular Docking Studies

The Synthesis, Characterization, DNA/protein Interaction, Molecular Docking and Catecholase Activity of Two Co(II) Complexes Constructed from the Aroylhydrazone Ligand

Syntheses, Crystal Structures and DNA-binding Properties of Zn(II), Ni(II) and Co(II) Compounds Containing Thiazole Derivatives

DNA interaction studies of cobalt (II) mixed-ligand complexes containing dimethyl-1, 10-phenanthroline and dipyrido[3,2-a:2',3'-c]phenazine: the role of methyl substitutions on the mode of binding

Structure and spectral performance of Co(II) and Co(III) complexes for DNA-binding: Synthesis, characterization and comparison

Synthesis, characterization, X-ray Crystallography, Photoluminescence property and DNA binding activity of Co(II) and Ni(II) complexes of a pyrazole-containing Schiff-base ligand

Crystal Structure, Anticancer, and Antimicrobial Evaluation of a Novel Substituted Pyrazole Ligand and Its Co(II), Ni(II), and Zn(II) Complexes